AIM ImmunoTech
36 hedge funds and large institutions have $4.68M invested in AIM ImmunoTech in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 35 → 36 (+1)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
34% less capital invested
Capital invested by funds: $7.12M → $4.68M (-$2.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$36K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$29.9K |
| 3 |
FWM
ForthRight Wealth Management
Alpharetta,
Georgia
|
+$19.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.3K |
| 5 |
Jane Street
New York
|
+$9.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$377K |
| 2 |
Renaissance Technologies
New York
|
-$296K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$89K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.4K |
| 5 |
Millennium Management
New York
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| $8K | +$9.98K | +104 | New |
|
27
UBS Group
Zurich,
Switzerland
| $4K | +$5.09K | +53 | New |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$960 | +10 | +67% |
|
|
SC
29
Stephens Consulting
Flint,
Michigan
| $1.17K | – | – | – |
|
|
HI
30
Hoey Investments
Coatesville,
Pennsylvania
| $1K | – | – | – |
|
|
APA
31
American Portfolios Advisors
Holbrook,
New York
| $178 | – | – | – |
|
|
TWC
32
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $171 | – | – | – |
|
|
33
Dimensional Fund Advisors
Austin,
Texas
| – | -$89K | -836 | Closed |
|
|
34
Bank of America
Charlotte,
North Carolina
| – | -$14.4K | -150 | Closed |
|
|
35
Millennium Management
New York
| – | -$14K | -130 | Closed |
|
|
SSA
36
Schonfeld Strategic Advisors
New York
| – | -$11K | -108 | Closed |
|
|
HR
37
Howe & Rusling
Rochester,
New York
| – | -$2K | -15 | Closed |
|
AIM Hedge Fund Activity: Q2 2022 in Review
36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2022, worth a combined $4.68M — down 34% from $7.12M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AIM positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Raymond James Financial Services Advisors, opening a new position worth an estimated $36K. The largest seller was Morgan Stanley, cutting an estimated $377K.
- 36 institutional investors held AIM ImmunoTech (AIM) as of Q2 2022, up from 35 in Q1 2022.
- Funds reported $4.68M of AIM ImmunoTech stock for Q2 2022, down 34% quarter-over-quarter.
- 6 funds opened new AIM ImmunoTech positions in Q2 2022 and 5 closed out, a net change of +1 holder.
- The largest AIM ImmunoTech buyer in Q2 2022 was Raymond James Financial Services Advisors, an estimated $36K added.
- The largest AIM ImmunoTech seller in Q2 2022 was Morgan Stanley, an estimated $377K sold.
Based on aggregated 13F filings for Q2 2022.